Tumor angiogenesis modulates leukocyte-vessel wall interactions in Vivo by reducing endothelial adhesion molecule expression

Cancer Research

Volumn 63, Issue 9, 2003, Pages 2322-2329

  Dirkx, Anita E M ^a   Oude Egbrink, Mirjam G A ^b   Kuijpers, Marijke J E ^b   Van der Niet, Sandra T ^a   Heijnen, Viviane V T ^b   Bouma ter Steege, Jessica C A ^a   Wagstaff, John ^a   Griffioen, Arjan W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CELL INTERACTION; CELL ISOLATION; CELL SORTER; COLON CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; EAR; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKOCYTE; MELANOMA; MICROSCOPY; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BLOOD VESSEL; TUMOR GROWTH; VENULE; XENOGRAFT;

ANIMALS; CELL COMMUNICATION; COLONIC NEOPLASMS; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0037699015     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Chang, A. E., and Shu, S. Current status of adoptive immunotherapy of cancer. Crit. Rev. Oncol. Hematol., 22: 213-228, 1996.
2. Arca, M. J., Mule, J. J., and Chang, A. E. Genetic approaches to adoptive cellular therapy of malignancy. Semin. Oncol., 23: 108-117, 1996.
3. Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration-the multistep paradigm. Cell, 76: 301-314, 1994.
4. Griffioen, A. W., Damen, C. A., Martinotti, S., Blijham, G. H., and Groenewegen, G. Endothelial ICAM-1 expression is suppressed in human malignancies; role of angiogenic factors. Cancer Res., 56: 1111-1117, 1996.
5. Pawelec, G., Heinzel, S., Kiessling, R., Muller, L., Ouyang, Q., and Zeuthen, J. Escape mechanisms in tumor immunity: a year 2000 update. Crit. Rev. Oncog., 11: 97-133, 2000.
6. Griffioen, A. W. Phenotype of the tumor vasculature; cell adhesion as a target for tumor therapy. Cancer J., 10: 249-255, 1997.
7. Melder, R. J., Koenig, G. C., Witwer, B. P., Safabakhsh, N., Munn, L. L., and Jain, R. K. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat. Med., 2: 992-997, 1996.
8. Griffioen, A. W., and Molema, G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases and chronic inflammation. Pharmacol. Rev., 52: 237-268, 2000.
9. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
10. Hellwig, S. M. M., Damen, C. A., Van Adrichem, N. P. H., Groenewegen, G., Blijham, G. H., and Griffioen, A. W. Endothelial CD34 is suppressed in human malignancies; role of angiogenic factors. Cancer Lett., 120: 203-211, 1997.
11. Griffioen, A. W., Damen, C. A., Blijham, G. H., and Groenewegen, G. Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor associated endothelium. Blood, 88: 667-673, 1996.
12. Griffioen, A. W., Tromp, S. C., and Hillen, H. F. P. Angiogenesis modulates the tumor immune response. Int. J. Exp. Pathol., 79: 363-368, 1998.
13. Griffioen, A. W., Relou, I. A. M., Gallardo Torres, H. I., Damen, C. A., Martinotti, S., De Graaf, J. C., Zwaginga, J. J., and Groenewegen, G. Tumor angiogenesis impairs leukocyte adhesion and rolling under flow conditions. Angiogenesis, 2: 45-50, 1999.
14. Tromp, S. C., oude Egbrink, M. G. A., Dings, R. P. M., Van Velzen, S., Slaaf, D. W., Hillen, H. F. P., Tangelder, G. J., Reneman, R. S., and Griffioen, A. W. Tumor angiogenesis factors reduce leukocyte adhesion in vivo. Int. Immunol., 12: 671-676, 2000.
15. Slaaf, D. W., Alewijnse, R., and Wayland, H. Use of telescopic imaging in intravital microscopy: a simple solution for conventional microscopes. Int. J. Microcirc. Clin. Exp., 1: 121-134, 1982.
16. Intaglietta, M., and Tompkins, W. R. Microvascular measurements by video image shearing and splitting. Microvasc. Res., 5: 309-312, 1973.
17. Bessa, X., Elizalde, J. I., Mitjans, F., Pinol, V., Miquel, R., Panes, J., Piulats, J., Pique, J. M., and Castells, A. Leukocyte recruitment in colon cancer: role of cell adhesion molecules, nitric oxide, and transforming growth factor β1. Gastroenterology, 122: 1122-1132, 2002.
18. Ryschich, E., Schmidt, J., Hammerling, G. J., Klar, E., and Ganss, R. Transformation of the microvascular system during multistage tumorigenesis. Int. J. Cancer, 97: 719-725, 2002.
19. Schmidt, J., Ryschich, E., Maksan, S. M., Werner, J., Gebhard, M. M., Herfarth, C., and Klar, E. Reduced basal and stimulated leukocyte adherence in tumor endothelium of experimental pancreatic cancer. Int. J. Pancreatol., 26: 173-179, 1999.
20. Fukumura, D., Salehi, H. A., Witwer, B., Tuma, R. F., Melder, R. J., and Jain, R. K. Tumor necrosis factor α-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. Cancer Res., 55: 4824-4829, 1995.
21. Wu, N. Z., Klitzman, B., Dodge, R., and Dewhirst, M. W. Diminished leukocyteendothelium interaction in tumor microvessels. Cancer Res., 52: 4265-4268, 1992.
22. Wu, N. Z., Ross, B. A., Gulledge, C., Klitzman, B., Dodge, R., and Dewhirst, M. W. Differences in leucocyte-endothelium interactions between normal and adenocarcinoma bearing tissues in response to radiation. Br. J. Cancer, 69: 883-889, 1994.
23. Teshima, T., Mach, N., Hill, G. R., Pan, L., Gillessen, S., Dranoff, G., and Ferrara, J. L. Tumor cell vaccine elicits potent antitumor immunity after allogeneic Tcell-depleted bone marrow transplantation. Cancer Res., 61: 162-171, 2001.
24. Schreurs, M. W., Eggert, A. A., de Boer, A. J., Vissers, J. L., van Hall, T., Offringa, R., Figdor, C. G., and Adema, G. J. Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model. Cancer Res., 60: 6995-7001, 2000.
25. Todryk, S. M., Birchall, L. J., Erlich, R., Halanek, N., Orleans-Lindsay, J. K., and Dalgleish, A. G. Efficacy of cytokine gene transfection may differ for autologous and allogeneic tumour cell vaccines. Immunology, 102: 190-198, 2001.
26. Akiyama, Y., Watanabe, M., Maruyama, K., Ruscetti, F. W., Wiltrout, R. H., and Yamaguchi, K. Enhancement of antitumor immunity against B16 melanoma tumor using genetically modified dendritic cells to produce cytokines. Gene Ther., 7: 2113-2121, 2000.
27. Piali, L., Fichtel, A., Terpe, H. J., Imhof, B. A., and Gisler, R. H. Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma. J. Exp. Med., 181: 811-816, 1995.
28. Madhavan, M., Srinivas, P., Abraham, E., Ahmed, I., Vijayalekshmi, N. R., and Balaram, P. Down regulation of endothelial adhesion molecules in node positive breast cancer: possible failure of host defence mechanism. Pathol. Oncol. Res., 8: 125-128, 2002.
29. Zhang, H., and Issekutz, A. C. Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668. Am. J. Pathol., 160: 2219-2230, 2002.
30. Torcia, M., Lucibello, M., De Chiara, G., Labardi, D., Nencioni, L., Bonini, P., Garaci, E., and Cozzolino, F. Interferon-α-induced inhibition of B16 melanoma cell proliferation: interference with the bFGF autocrine growth circuit. Biochem. Biophys. Res. Commun., 262: 838-844, 1999.
31. Huang, T. F., Yeh, C. H., and Wu, W. B. Viper venom components affecting angiogenesis. Haemostasis, 31: 192-206, 2001.
32. Scalia, R., Booth, G., and Lefer, D. J. Vascular endothelial growth factor attenuates leukocyte-endothelium interaction during acute endothelial dysfunction: essential role of endothelium-derived nitric oxide. FASEB J., 13: 1039-1046, 1999.
33. Kim, I., Moon, S. O., Kim, S. H., Kim, H. J., Koh, Y. S., and Koh, G. Y. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-κ B activation in endothelial cells. J. Biol. Chem., 276: 7614-7620, 2001.
34. Detmar, M., Brown, L. F., Schon, M. P., Elicker, B. M., Velasco, P., Richard, L., Fukumura, D., Monsky, W., Claffey, K. P., and Jain, R. K. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Investig. Dermatol., 111: 1-6, 1998.
35. Aderka, D., Englemann, H., Hornik, V., Skornick, Y., Levo, Y., Wallach, D., and Kushtai, G. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res., 51: 5602-5607, 1991.
36. Gadducci, A., Ferdeghini, M., Fanucchi, A., Annicchiarico, C., Prato, B., Prontera, C., Facchini, V., and Genazzani, A. R. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer. Anticancer Res., 16: 3125-3128, 1996.
37. Nooijen, P. T., Westphal, J. R., Eggermont, A. M., Schalkwijk, C., Max, R., de Waal, R. M., and Ruiter, D. J. Endothelial P-selectin expression is reduced in advanced primary melanoma and melanoma metastasis. Am. J. Pathol., 152: 679-682, 1998.